it was longer, sometimes it was less. These days I'm doing much more active trading. So it's not so much focused on a catalyst. Basically, if the sector is rising, I find some names that look exciting. But that being said, one of my favorite stocks is Ligand, LGND. Sorry, LGND is the symbol. And what I like about them is they are... Royalties, right? Yeah, and they're not focused on getting that clinical trial data to come in strong or that one FDA approval that's going to make or break the company. They have well over 100 different compounds. Some there are still in development, some are licensed to other companies that are on the market and where the big pharmas are developing them. So when that happens, the risk is off for Ligand. And basically when something positive happens, like a strong clinical trial, they'll usually get a milestone payment. And when it hits the market, they just sit back and collect the royalties. So really, their business model is find these molecules, find (24/35)